MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the quarter ending 2026-03-29, ILMN made $1,091M in revenue. $134M in net income. Net profit margin of 12.28%.

Income Overview

Revenue
$1,091M
Net Income
$134M
Net Profit Margin
12.28%
EPS
$0.87
Unit: Million (M) dollars
Revenue Breakdown
    • Product
    • Service
Revenue Breakdown
    • Sequencing
    • Microarray
Revenue Breakdown
    • United States And Canada
    • EMEA
    • Asia Pacific
    • CN
Revenue Breakdown
    • total cost of revenue
    • research and development
    • net income (loss)
    • Others

Income Statement
2026-03-29
2025-12-28
2025-09-28
2025-06-29
Total revenue
1,091 1,159 1,084 1,059
Cost of revenue-Product
273 311 267 276
Cost of revenue-Service
80 73 68 71
Amortization of acquired intangible assets
17 16 16 17
Total cost of revenue
370 400 351 364
Gross profit
721 759 733 695
Research and development
240 239 229 247
Selling, general and administrative
272 308 277 234
Goodwill and intangible impairment
-0* 0 0
Legal contingency and settlement
--10* 0 -
Total operating expense
512 557 506 481
Income from operations
209 202 227 214
Interest income
11 10 9 10
Interest expense
24 26 25 25
Other (expense) income, net
-39 192 9 107
Total other (expense) income, net
-52 176 -7 92
Income before income taxes
157 378 220 306
Provision for income taxes
23 44 70 71
Net income
134 334 150 235
Basic EPS
0.88 2.212 0.98 1.49
Diluted EPS
0.87 2.169 0.98 1.49
Basic Average Shares
153,000,000 151,000,000 153,000,000 157,000,000
Diluted Average Shares
154,000,000 154,000,000 154,000,000 157,000,000
Unit: Million (M) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.

Time Plot

Show the time plot by selecting a row from the table.

Income Statement

DownloadDownload image
Sequencing$844M (4.84%↑ Y/Y)Microarray$73M (-2.67%↓ Y/Y)Sequencing$151M (6.34%↑ Y/Y)Microarray$23M (21.05%↑ Y/Y)Product$917M (4.20%↑ Y/Y)Service$174M (8.07%↑ Y/Y)Total revenue$1,091M (4.80%↑ Y/Y)Gross profit$721M (5.56%↑ Y/Y)Total cost of revenue$370M (3.35%↑ Y/Y)Income from operations$209M (27.44%↑ Y/Y)Total operatingexpense$512M (-1.35%↓ Y/Y)Cost ofrevenue-Product$273M (7.91%↑ Y/Y)Cost ofrevenue-Service$80M (-9.09%↓ Y/Y)Amortization of acquiredintangible assets$17M (0.00%↑ Y/Y)Income before incometaxes$157M (-13.74%↓ Y/Y)Total other (expense)income, net-$52M (-388.89%↓ Y/Y)Interest income$11M (0.00%↑ Y/Y)Selling, general andadministrative$272M (1.87%↑ Y/Y)Research and development$240M (-4.76%↓ Y/Y)Net income$134M (2.29%↑ Y/Y)Provision for income taxes$23M (-54.90%↓ Y/Y)Other (expense)income, net-$39M (-221.88%↓ Y/Y)Interest expense$24M (-4.00%↓ Y/Y)

ILLUMINA, INC. (ILMN)

ILLUMINA, INC. (ILMN)